UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Analysis of “On/Off” Kinetics of a CETP Inhibitor Using a Mechanistic Model of Lipoprotein Metabolism and Kinetics

CPT: pharmacometrics and systems pharmacology, 2015-08, Vol.4 (8), p.465-473

2015

Volltextzugriff (PDF)

P.363JEWELFISH: safety and pharmacodynamic data in patients with spinal muscular atrophy (SMA) receiving treatment with risdiplam (RG7916) that have previously been treated with nusinersen

Neuromuscular disorders : NMD, 2019-10, Vol.29, p.S187-S187

2019

Volltextzugriff (PDF)

O.41Sunfish part 1: 18-month safety and exploratory outcomes of risdiplam (RG7916) treatment in patients with type 2 or 3 spinal muscular atrophy

Neuromuscular disorders : NMD, 2019-10, Vol.29, p.S208-S208

2019

Volltextzugriff (PDF)

SMA THERAPIES II AND BIOMARKERS: P.257JEWELFISH: RG7916 increases SMN protein in patients with SMA that have previously received therapies targeting SMN2 splicing

Neuromuscular disorders : NMD, 2018-10, Vol.28, p.S109-S109

2018

Volltextzugriff (PDF)

SMA THERAPIES II AND BIOMARKERS

Neuromuscular disorders : NMD, 2018-10, Vol.28, p.S109

2018

Volltextzugriff (PDF)

Clinical Drug–Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor Alectinib

Clinical pharmacology in drug development, 2017-05, Vol.6 (3), p.280-291

2017

Volltextzugriff (PDF)

P.353FIREFISH Part 1: 16-month safety and exploratory outcomes of risdiplam (RG7916) treatment in infants with type 1 spinal muscular atrophy

Neuromuscular disorders : NMD, 2019-10, Vol.29, p.S184-S184

2019

Volltextzugriff (PDF)

SMA THERAPIES II AND BIOMARKERS: P.255SUNFISH Part 1: RG7916 treatment results in a sustained increase of SMN protein levels and the first clinical efficacy results in patients with type 2 or 3 SMA

Neuromuscular disorders : NMD, 2018-10, Vol.28, p.S108-S108

2018

Volltextzugriff (PDF)

SMA THERAPIES II AND BIOMARKERS

Neuromuscular disorders : NMD, 2018-10, Vol.28, p.S109-S110

2018

Volltextzugriff (PDF)

SMA THERAPIES II AND BIOMARKERS

Neuromuscular disorders : NMD, 2018-10, Vol.28, p.S108

2018

Volltextzugriff (PDF)

SMA THERAPIES II AND BIOMARKERS: P.258FIREFISH Part 1: early clinical results following a significant increase of SMN protein in SMA type 1 babies treated with RG7916

Neuromuscular disorders : NMD, 2018-10, Vol.28, p.S109-S109

2018

Volltextzugriff (PDF)

SMA THERAPIES II AND BIOMARKERS: P.259SMN protein levels before and after treatment with RG7916 in type 1, 2 and 3 SMA patients compared to healthy subjects

Neuromuscular disorders : NMD, 2018-10, Vol.28, p.S109-S110

2018

Volltextzugriff (PDF)

SMA THERAPIES II AND BIOMARKERS

Neuromuscular disorders : NMD, 2018-10, Vol.28, p.S109

2018

Volltextzugriff (PDF)

P.063 SUNFISH Part 1 results and Part 2 trial design in patients with type 2/3 spinal muscular atrophy (SMA) receiving risdiplam (RG7916)

Canadian journal of neurological sciences, 2019-06, Vol.46 (s1), p.S31-S31

2019

Volltextzugriff (PDF)

Leadership Roles, Socioemotional Communication Strategies, and Technology Use of Irish and US Students in Virtual Teams

IEEE transactions on professional communication, 2010-06, Vol.53 (2), p.89-101

2010

Volltextzugriff (PDF)

P.064 FIREFISH Part 1: 1-year results on motor function in infants with Type 1 spinal muscular atrophy (SMA) receiving risdiplam (RG7916)

Canadian journal of neurological sciences, 2019-06, Vol.46 (s1), p.S31-S31

2019

Volltextzugriff (PDF)

CLINICAL DRUG-DRUG INTERACTIONS (DDIS) THROUGH CYTOCHROME P450 3A (CYP3A) FOR ALECTINIB, A HIGHLY SELECTIVE ALK INHIBITOR

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, Vol.99, p.S62

2016

Volltextzugriff (PDF)

Disability discrimination

Mental health care, 1997-10, Vol.1 (2), p.68

Cleary, Y

1997

Volltextzugriff (PDF)

Coupling the porous conditional moment closure with the random pore model： applications to gasification and C02 capture

化学科学与工程前沿：英文版, 2012, Vol.6 (1), p.84-93

D. N. SAULOV C. R. CHODANKA M. J. CLEARY A. Y. KLIMENKO

2012

Volltextzugriff (PDF)

Le bouquetin dans l’art paléolithique en Europe méditerranéenne

2010

Volltextzugriff (PDF)

Technical communication at the University of Limerick: comparison of available data for distance learning and full-time students

IPCC 2005. Proceedings. International Professional Communication Conference, 2005, 2005, p.689-697

Cleary, Y.

2005

Volltextzugriff (PDF)

Preparing technical communication students for their role in the information economy: Client-based virtual team collaboration between Irish and US students

2008 IEEE International Professional Communication Conference, 2008, p.1-10

2008

Volltextzugriff (PDF)

Technology Use and Communication Strategies of Irish and US Students in Virtual Teams

2007 IEEE International Professional Communication Conference, 2007, p.1-8

2007

Volltextzugriff (PDF)

Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer

Nature (London), 2022-03, Vol.603 (7903), p.942-948

2022

Volltextzugriff (PDF)

1 – 25 von 474

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(416)
Mit Volltextzugriff
(403)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(258)
Life Sciences & Biomedicine
(192)
Humans
(149)
Biological And Medical Sciences
(92)
Female
(74)
Medical Sciences
(71)
Male
(68)
Animals
(54)
Adult
(50)
Middle Aged
(50)
Physical Sciences
(43)
Aged
(39)
Technology
(39)
Oncology
(37)
Mice
(36)
Tumors
(31)
Engineering
(28)
Fundamental And Applied Biological Sciences. Psychology
(26)
Gastroenterology. Liver. Pancreas. Abdomen
(25)
Pathology
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Analysis of “On/Off” Kinetics of a CETP Inhibitor Using a Mechanistic Model of Lipoprotein Metabolism and Kinetics

P.363JEWELFISH: safety and pharmacodynamic data in patients with spinal muscular atrophy (SMA) receiving treatment with risdiplam (RG7916) that have previously been treated with nusinersen

O.41Sunfish part 1: 18-month safety and exploratory outcomes of risdiplam (RG7916) treatment in patients with type 2 or 3 spinal muscular atrophy

SMA THERAPIES II AND BIOMARKERS: P.257JEWELFISH: RG7916 increases SMN protein in patients with SMA that have previously received therapies targeting SMN2 splicing

SMA THERAPIES II AND BIOMARKERS

Clinical Drug–Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor Alectinib

P.353FIREFISH Part 1: 16-month safety and exploratory outcomes of risdiplam (RG7916) treatment in infants with type 1 spinal muscular atrophy

SMA THERAPIES II AND BIOMARKERS: P.255SUNFISH Part 1: RG7916 treatment results in a sustained increase of SMN protein levels and the first clinical efficacy results in patients with type 2 or 3 SMA

SMA THERAPIES II AND BIOMARKERS

SMA THERAPIES II AND BIOMARKERS

SMA THERAPIES II AND BIOMARKERS: P.258FIREFISH Part 1: early clinical results following a significant increase of SMN protein in SMA type 1 babies treated with RG7916

SMA THERAPIES II AND BIOMARKERS: P.259SMN protein levels before and after treatment with RG7916 in type 1, 2 and 3 SMA patients compared to healthy subjects

SMA THERAPIES II AND BIOMARKERS

P.063 SUNFISH Part 1 results and Part 2 trial design in patients with type 2/3 spinal muscular atrophy (SMA) receiving risdiplam (RG7916)

Leadership Roles, Socioemotional Communication Strategies, and Technology Use of Irish and US Students in Virtual Teams

P.064 FIREFISH Part 1: 1-year results on motor function in infants with Type 1 spinal muscular atrophy (SMA) receiving risdiplam (RG7916)

CLINICAL DRUG-DRUG INTERACTIONS (DDIS) THROUGH CYTOCHROME P450 3A (CYP3A) FOR ALECTINIB, A HIGHLY SELECTIVE ALK INHIBITOR

Les sépultures individuelles campaniformes en France

Disability discrimination

Coupling the porous conditional moment closure with the random pore model： applications to gasification and C02 capture

Le bouquetin dans l’art paléolithique en Europe méditerranéenne

Technical communication at the University of Limerick: comparison of available data for distance learning and full-time students

Preparing technical communication students for their role in the information economy: Client-based virtual team collaboration between Irish and US students

Technology Use and Communication Strategies of Irish and US Students in Virtual Teams

Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer

Suchergebnisse filtern